It’s a great pleasure announce the end of the recruitment for the SPRINT-T clinical trial, with 1519 participants enrolled and randomized into either the HALE group or the MCI group in 10 European countries.
People that are participating at the trial will continue their activities until the end of the trial which is scheduled in January 2019.